Electronic alternatives to painkillers have long promised drug-free relief, but existing nerve-stimulation approaches carry their own burdens: electrodes and lead wires attached to nerves can cause inflammation and side effects, and implanted batteries eventually demand replacement surgery. A team from Yonsei's Department of Materials Science and Engineering, led by Kim Sang-woo and Lee Kyu-hyoung, working with Choi Byung-ok of Samsung Medical Center, has reported a design that removes all three problems at once.
Their device, described in Nature Biomedical Engineering and announced in January 2026, is a biocompatible medical polymer placed near the target nerves during surgery, with no battery, electrodes or wiring. When pain strikes, ultrasound applied from outside the body drives the polymer to generate triboelectric energy internally, and that electrical activity blocks pain signals without drugs. In animal testing, pain signalling dropped immediately when the ultrasound was switched on and recovered quickly when it was switched off, demonstrating on-demand control.
The exit strategy is built into the material: the polymer degrades naturally inside the body over time, so no removal operation is needed. The concept, an electroceutical that is wireless in power, wireless in control and self-clearing when its work is done, suggests a path for post-surgical pain management that sidesteps both opioid pharmacology and the hardware burden of conventional neurostimulators.